Article: A-108 MONITORING ISSUES OF DIRECT ANTI-XA ORAL ANTICOAGULANTS AND LOW MOLECULAR WEIGHT HEPARINS, DURING BRIDGING WITH LMWH THERAPY

2.42

SKU: product-article-16646 Category:

Description

A-108 MONITORING ISSUES OF DIRECT ANTI-XA ORAL ANTICOAGULANTS AND LOW MOLECULAR WEIGHT HEPARINS, DURING BRIDGING WITH LMWH THERAPY

Reviews

There are no reviews yet.

Be the first to review “Article: A-108 MONITORING ISSUES OF DIRECT ANTI-XA ORAL ANTICOAGULANTS AND LOW MOLECULAR WEIGHT HEPARINS, DURING BRIDGING WITH LMWH THERAPY”

Your email address will not be published. Required fields are marked *